708 related articles for article (PubMed ID: 18682947)
1. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
Eroglu A; Egin Y; Cam R; Akar N
Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
[TBL] [Abstract][Full Text] [Related]
2. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Kabukcu S; Keskin N; Keskin A; Atalay E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
[TBL] [Abstract][Full Text] [Related]
3. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
5. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.
Ozbek N; Ataç FB; Yildirim SV; Verdi H; Yazici C; Yilmaz BT; Tokel NK
Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156
[TBL] [Abstract][Full Text] [Related]
9. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
Eid SS; Rihani G
Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
[TBL] [Abstract][Full Text] [Related]
13. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.
Eroğlu A; Akar N
Thromb Res; 2011 Apr; 127(4):384-5. PubMed ID: 21093891
[No Abstract] [Full Text] [Related]
15. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
17. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
Kim RJ; Becker RC
Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
[TBL] [Abstract][Full Text] [Related]
18. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
Koksal V; Baris I; Etlik O
Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]